生物科技公司Illumina风险投资建设负责人卡萨斯离职——全球风险投资
Biotech company Illumina loses venture building head Casas - - Global Venturing
生物技术与制药领域的最新动态
Biotech company Illumina loses venture building head Casas - - Global Venturing
Maintaining sexual identity in adult flies is an ongoing commitment
Aging-related peroxisomal dysregulation disrupts intestinal stem cell differentiation through alterations of very long-chain fatty acid oxidation
Whalen Wealth Management Inc. Has $1.64 Million Stock Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Joe Jimenez's Aditum goes to Fosun for major biobuck-loaded collaboration
Chia Tai Tianqing Pharmaceutical patents new AKT1 inhibitors
Aché Laboratórios Farmacêuticos divulges new compounds for respiratory disorders
Haisco Pharmaceutical describes new IL-17A production inhibitors
New platinum complex prodrugs disclosed in Beijing Changping Laboratory patent
Biogen’s CIO is betting on a tech and AI overhaul to ‘pave the highways’ toward growth
Catalent handed two Form 483s, including for Sarepta gene therapy site
Galapagos ends turbulent year with mixed results for last remaining immunology asset
Boehringer walks away from Nxera's phase 2-ready schizophrenia program
Endpoints at JPM 2026: What we'll be talking about
Lancaster Investment Management Purchases Shares of 621,779 10x Genomics $TXG - MarketBeat
Talbot Financial LLC Has $12.80 Million Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific plans collaboration hub for Philly’s life sciences startups - Technical.ly
Barclays Maintains Agilent Technologies(A.US) With Buy Rating, Maintains Target Price $165 - 富途牛牛
DNA and RNA Sample Preparation Market Is Going to Boom | Agilent - openPR.com
Why Waters Corporation (WAZ) stock appeals to dividend investors - July 2025 Breakouts & Daily Profit Focused Stock Screening - DonanımHaber